Medicine Overview of New Lemolinctus Syrup
Nausea, Vomiting, Bloating, Diarrhoea, Indigestion, Loss of appetite, Dizziness, Headache, Sweating, Sleepiness, Insomnia (difficulty in sleeping), Skin rash, Itching, Allergic reaction.
Take this medicine in the dose and duration as advised by your doctor. Check the label for directions before use. Measure it with a measuring cup and take it by mouth. Shake well before use. New Lemolinctus Syrup may be taken with or without food, but it is better to take it at a fixed time.
Take it with food if stomach upset occurs.
New Lemolinctus Syrup is a combination of four medicines: Bromhexine, chlorpheniramine, paracetamol and phenylephrine which relieve common cold symptoms. Bromhexine is a mucolytic which thins and loosens mucus (phlegm), making it easier to cough out. Chlorpheniramine is an antiallergic which relieves allergy symptoms like runny nose, watery eyes and sneezing. Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer). It blocks the release of certain chemical messengers in the brain that are responsible for pain and fever. Phenylephrine is a decongestant which narrows the small blood vessels providing relief from congestion or stuffiness in the nose.
In Depth Information on New Lemolinctus Syrup
New Lemolinctus Syrup related warnings
Taking Bromhexine+Chlorpheniramine+Paracetamol / Acetaminophen+Phenylephrine with alcohol can cause liver damage.
WEIGH RISKS VS BENEFITS
New Lemolinctus Syrup may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
No information is available on the use of New Lemolinctus Syrup during lactation. Please consult your doctor.
New Lemolinctus Syrup may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
New Lemolinctus Syrup is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of New Lemolinctus Syrup may not be needed in these patients. Please consult your doctor.
Use of New Lemolinctus Syrup may cause excessive sleepiness in patients with end stage kidney disease.
New Lemolinctus Syrup should be used with caution in patients with liver disease. Dose adjustment of New Lemolinctus Syrup may be needed. Please consult your doctor.
One of the following vendor pharmacies will deliver New Lemolinctus Syrup: HAT, RPP, BAP, EVP, CHP, RHW, OLT, MDH, SLN, BHM, ESY, ABP, AAY, HIP, HGI, HZF, SCH, HBV, MSD, SAF, DAO, AMR, AYM, FGH, RSA, OIP, LHA, KIS, KHC, IAD, BMJ, BHP, MAM, GTK, DGN, DHR, TRP, TOM, HSP, SHC, ANT, NVL, UBL, NXG, 9T9, TNH, DZY, SGH, SGC, PRN, AGT, VNS, P2P, TFP, WHL, RDR, BIO, JVN, JSL, RWP, HNP, USF, MAK, NNP, GPP, NTB, BLE, VRS, HTS, SDM, NVY, DYG, MPC, EQN, NWP, EPS, GBL, SHD, PTI, UMP, GPT, BSN, MAP, ATP, AVS, KHH, RKS, SWP, JIV, SVH, KMC, DPP, AYU, QTM, RSS, SWA, SRG, SSA, DPL, BBS, BGS, ATL, ADT, QLF, SPD, NAS, INC, JBT, STA, ARD, HEX, GHR, BLS, PLT, NSL, AWS, SJP, VJS, SBL, ZPR, OWP, ENP, GNC, NDP, EMB, LMS, WSI, PVP, THP, BTM, MDO, SYN, LCC, ZVP, MAX, DFP, RHL, RUS, DVH, PEN, HPC, DHP, RDH, OHM, MLC, SVS, PWN, AAR, PMA, BAL, GTC, HMP, IPL, MMS, PNT, SBA, RJH, BDN, RPI, CLT, JHC, PPR, BHS, SMN, ZEL, VDH, JVO